Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PRO-GLIO: PROton Versus Photon Therapy in IDH-mutated Diffuse Grade II and III GLIOmas

NCT05190172 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.

NCT NCT05190172
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05190172 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PRO-GLIO: PROton Versus Photon Therapy in IDH-mutated Diffuse Grade II and III GLIOmas
Lead sponsor
Oslo University Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
January 14, 2022
Completion date
December 31, 2045
Enrollment
225 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diffuse astrocytoma, idh-mutant, oligodendroglioma, oligodendroglioma, anaplastic